All Stories

  1. Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

    Article • Proceedings of the National Academy of Sciences, June 2021, Proceedings of the National Academy of Sciences

    Gerd Sutter, Professor (Associate) Bart L. Haagmans

  2. Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

    Article • Journal of Virology, May 2015, ASM Journals

    Gerd Sutter

  3. Rapid Expansion of CD8+ T Cells in Wild-Type and Type I Interferon Receptor-Deficient Mice Correlates with Protection after Low-Dose Emergency Immunization with Modified Vaccinia Virus Ankara

    Article • Journal of Virology, July 2014, ASM Journals

    Gerd Sutter

  4. Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies

    Article • Vaccine, September 2013, Elsevier

    Gerd Sutter

  5. Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies

    Article • Journal of Virology, August 2013, ASM Journals

    Gerd Sutter, Professor (Associate) Bart L. Haagmans